SCHEMBL4251441

SCHEMBL4251441

CCN1CC(C)(C)C(=O)C(C)(C)C1

nearest known ligand 0.34

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.34
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
F2 P00734 1/20 0.32
ELANE P08246 1/20 0.32
CTSG P08311 1/20 0.32
CTRC Q99895 1/20 0.32
ALOX15 P16050 1/20 0.31
KMT2A Q03164 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
CYP2C19 P33261 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14529579 0.73 GAA (0.42) GAASMN1; SMN2ALOX15KMT2AL3MBTL1
SCHEMBL13939995 0.69 TSHR (0.31)
SCHEMBL16978992 0.69
SCHEMBL24235272 0.67
SCHEMBL10207376 0.66 TSHR (0.41)
SCHEMBL20749854 0.65 TSHR (0.33)
SCHEMBL11919130 0.65
SCHEMBL24235263 0.65
SCHEMBL18458997 0.65
SCHEMBL26004263 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7608630-B2 Prepared by extracting fungi Marasmius androsaceus L.es Fr with an organic solvent, an aqueous organic solvent or water, and concentrating the obtained extractive; use in treatment of cardiovascular disorders HAINAN YANGPU NEW SPECIAL PHARMACEUTICAL CO., LTD. (CN) 2009-10-27 US claimed
US-20090253742-A1 MARASMIUS ANDROSACEUS L.ES FR EXTRACT, PIPERIDONE DERIVATIVE, AND THEIR USE FOR THE PREPARATION OF ANTIHYPERTENSIVES HAINAN YANGPU NEW SPECIAL PHARMACEUTICAL CO., LTD. (CN) 2009-10-08 US claimed
US-7608630-B2 Prepared by extracting fungi Marasmius androsaceus L.es Fr with an organic solvent, an aqueous organic solvent or water, and concentrating the obtained extractive; use in treatment of cardiovascular disorders HAINAN YANGPU NEW SPECIAL PHARMACEUTICAL CO., LTD. (CN) 2009-10-27 US disclosed
US-20090253742-A1 MARASMIUS ANDROSACEUS L.ES FR EXTRACT, PIPERIDONE DERIVATIVE, AND THEIR USE FOR THE PREPARATION OF ANTIHYPERTENSIVES HAINAN YANGPU NEW SPECIAL PHARMACEUTICAL CO., LTD. (CN) 2009-10-08 US disclosed
US-20070160625-A1 Marasmius androsaceus l.es fr extract, piperidone derivative, and their use for the preparation of antihypertensives HAINAN YANGPU NEW SPECIAL PHARMACEUTICAL CO., LTD. (CN) 2007-07-12 US disclosed
EP-1710235-A1 EXTRACTS OF MARASMINS ANDROSACEUS L.ES, PIPERDINONE DERIVATIVES AND THE USE AS ANTIHYPERTENSIVE AGENTS Beijing Tuolin Medicine Science and Technology Co., Ltd. (CN) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253742-A1 MARASMIUS ANDROSACEUS L.ES FR EXTRACT, PIPERIDONE DERIVATIVE, AND THEIR USE FOR THE PREPARATION OF ANTIHYPERTENSIVES REN, PTGIS, EDNRA GAA 3835/4885RAB9A 2702/4885SMN1; SMN2 2532/4885
US-20070160625-A1 Marasmius androsaceus l.es fr extract, piperidone derivative, and their use for the preparation of antihypertensives REN, PTGIS, EDNRA GAA 3835/4885RAB9A 2702/4885SMN1; SMN2 2532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.